Expertise in
5
conditions

Dr. Mardi I. Gomberg-Maitland

Cardiology
Gw Cardiology-Foggy Bottom South Pavilion
2150 Pennsylvania Ave NW # 3, 
Washington,, DC 
Accepting New Patients
Referral may be required
Before you request
Expertise in
5
conditions
Gw Cardiology-Foggy Bottom South Pavilion
2150 Pennsylvania Ave NW # 3, 
Washington,, DC 

Overview

Mardi Gomberg-Maitland is a Cardiologist practicing medicine in Washington,, Washington, D.c..

Dr. Gomberg-Maitland is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Hypertension, Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure, and Heart Transplant.

She is actively involved in clinical research, co-authoring 123 peer reviewed articles and participating in 8 clinical trials. Dr. Gomberg-Maitland is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in IL

Hospital Affiliations

George Washington Univ Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Gw Cardiology-Foggy Bottom South Pavilion
2150 Pennsylvania Ave NW # 3, Washington,, DC 20037

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drug: Rodatristat Ethyl
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2024
Intervention Type: Drug
Study Drug: AV-101
Study Phase: Phase 2/Phase 3
Telemonitoring to Treat Group 2 Pulmonary Hypertension: A Personalized Approach
Telemonitoring to Treat Group 2 Pulmonary Hypertension: A Personalized Approach
Enrollment Status: Withdrawn
Publish Date: June 06, 2023
Intervention Type: Drug
Study Drug: Treprostinil Diolamine
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

123 Total Publications

REVEALing New Standards: Low Risk Redefined.
REVEALing New Standards: Low Risk Redefined.
Journal: JACC. Heart failure
Published: May 25, 2026
Similar Doctors
Expertise in
36
conditions
Expertise in
36
conditions
Referral may be required
Before you request

110 Irving Street Northwest Suite 4B-1

110 Irving St NW Ste 4B-1, 
Washington, DC 
 (2.7 miles away)
202-877-7464
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lowell Satler is a Cardiologist practicing medicine in Washington, Washington, D.c.. Dr. Satler is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Aortic Regurgitation, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Satler is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required
Before you request

110 Irving St., Nw 1st Floor-North Addition

110 Irving St NW, 
Washington, DC 
 (3.0 miles away)
202-877-7464
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Farooq Sheikh is a Cardiologist practicing medicine in Washington, Washington, D.c.. Dr. Sheikh is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Sarcoidosis, Cardiomyopathy, Heart Failure, Heart Transplant, and Cardiac Ablation. Dr. Sheikh is currently accepting new patients.

Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required
Before you request

Trueyou Center LLC

611 Pennsylvania Ave SE, 
Washington,, DC 
 (3.2 miles away)
202-548-2610
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gary Mintz is a Cardiologist practicing medicine in Washington,, Washington, D.c.. Dr. Mintz is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Acute Coronary Syndrome, Heart Attack, Atherectomy, and Percutaneous Coronary Intervention (PCI). Dr. Mintz is currently accepting new patients.

Frequently Asked Questions about Dr. Mardi I. Gomberg-Maitland

How do I make an appointment with Dr. Mardi I. Gomberg-Maitland?

You can book an appointment with Dr. Mardi I. Gomberg-Maitland by calling their office at 202-741-2323. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mardi I. Gomberg-Maitland a top-rated expert for Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mardi I. Gomberg-Maitland is classified as an Elite expert for Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mardi I. Gomberg-Maitland specialize in?

While Dr. Mardi I. Gomberg-Maitland is a Cardiology, they have specific expertise in Hypertension, Pulmonary Hypertension, and Pulmonary Veno-Occlusive Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Mardi I. Gomberg-Maitland participate in research or clinical trials?

Yes. Dr. Mardi I. Gomberg-Maitland has published 123 articles and abstracts on conditions like Hypertension. You can view a list of Dr. Mardi I. Gomberg-Maitland's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mardi I. Gomberg-Maitland accept my insurance?

Dr. Mardi I. Gomberg-Maitland accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 202-741-2323 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gomberg-Maitland's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile